Method for treating amyotrophic lateral sclerosis and a therapeu

Details Method for treating amyotrophic lateral sclerosis and a therapeu Method for treating amyotrophic lateral sclerosis and a therapeu

1998-02-06

1999-10-12

Yu, Mickey

Surgery

Miscellaneous

Methods

128897, A61B 1900

Patent

active

059642246

ABSTRACT:
A method for treating amyotrophic lateral sclerosis (ALS) and a therapeutic agent therefor are provided. The therapeutic agent comprising ultra-high doses of methylcobalamin (for example, from about 15 mg to about 500 mg per day) is administered to a patient with ALS intramuscularly, subcutaneously or intravenously for from about a week to about 2 years to ameliorate or improve both the clinical symptoms and an objective clinical measure in ALS or retard the muscle weakness caused by ALS.

REFERENCES:
Lacomblez et al. "Dose-ranging study of riluzole in amyotrophic lateral sclerosis" The Lancet 347 , 1425-431 (1996).
Cudkowicz et al. "Intrathecal administration of recombinant human superoxide . . . " Neurology 49, 215-222 (1997).
Dore et al. "Rediscovering an old friend, IGF-1: potential use in the treatment . . . " TINS 20, 326-331 (1997).
Friedlander et al. "Inhibition of ICE slows ALS in mice" Nature 388, 31 (1997).
Gourie-Devi et al. "Temporary amelioration of symptoms with intravenous . . . " J. Neur. Sci. 150, 167-172 (1997).
Gredal et al. "A clinical trial of dextromethorphan in amyotrophic lateral sclerosis" Acta Neurol Scand 96, 8-13 (1997).
Kostic et al. "Bcl-13 2: Prolonging Life in a Transgenic Mouse Model of Familial . . . " Science 277, 559-562 (*1997).
Penn et al. "Intrathecal Ciliary Neurotrophic Factor Delivery for Treatment . . . " Neurosurgery 40, 94-199 (1997).
Reider et al. "Lou Gehrig and Amyotrophic Lateral Sclerosis" Arch Neurol 54, 527-528 (1997).
Mizisin et al. "Toxic neuropathies" Current Opn. Neurology 8, 367-371 (1995).
Pfohl-Leszkowicz et al. "Effects of Cobalmin Derivatives on in Vitro Enzymatic DNA . . . " Biochem. 30, 8045-8051 (1991).
Akaike et al. "Protective effects of a vitamin B.sub.12 analog, methylcobalamin . . . " E. J. Pharm. 241, 1-6 (1993).
Watanabe et al. "Ultra-high dose methylcobalamin promotes nerve regeneration . . . " J. Neurol. Sci. 122, 140-143 (1994).
Kelley et al. "Use of Electrophysiologic Tests to Measure Disease Progression . . . " Muscle & Nerve 13, 471-479 (1990).
Kimura "Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice", Edition 2, 83-89 (1989).

Affiliated with

Also associated with

Rating

Method for treating amyotrophic lateral sclerosis and a therapeu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating amyotrophic lateral sclerosis and a therapeu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating amyotrophic lateral sclerosis and a therapeu will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-645093